Clinical trial Recruiting at 1 site Observational Ages Any age to 18

Evaluating autism in children and adolescents in Belgium

Official title: CAP48 Medical Research Project: Autism Spectrum Disorders in Children and Adolescents

Run by Université Catholique de Louvain · NCT06149468 · Data updated 2026-11-12

This study is trying to understand autism in children and teens in Belgium to improve how they are diagnosed and cared for, while also looking at how autism affects their education and families.

More Autism Spectrum Disorder trials

Quick facts

Study typeObservational
AgesAny age to 18 Years
SexAll
Enrollment500 (estimated)
SponsorUniversité Catholique de Louvain
Academic / other
Locations1 site (Brussels, Brussels Capital)
StatusRecruiting
StartedSeptember 15, 2023
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedMay 29, 2025
Trial IDNCT06149468 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children and adolescents under 18 years of age who are diagnosed with autism and are seeking care at autism reference centers in French-speaking Belgium.

Probably not a fit

Patients whose families refuse to allow their child's data to be included in the database will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate and follow children diagnosed with autism spectrum disorder (ASD) in French-speaking Belgium. It seeks to optimize diagnostic protocols and improve the quality and accessibility of care while assessing the impact of ASD on schooling, family, and society. The study will collect a wide range of socio-demographic, geographical, and epidemiological data to create a comprehensive database that characterizes different profiles and monitors developmental trajectories. Additionally, it will evaluate the feasibility of proposed treatments and develop research protocols to advance understanding of autism.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic and treatment protocols for children with autism, enhancing their quality of care.

How similar studies have gone: Other studies focusing on autism spectrum disorder have shown success in improving care and understanding of the condition, indicating that this approach is supported by prior research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* children/adolescents (under 18 years of age) who apply to an autism reference center or who are followed up in an autism reference center from French-speaking region of Belgium.

Exclusion Criteria:

* refusal by the family to allow their child's data to be included in the database.

Where it's running

  • UCLouvain
    Brussels, Brussels Capital, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.